Latest News and Press Releases
Want to stay updated on the latest news?
-
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK)...
-
Austin, TX, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Third Party Chemical Distribution Market Size, Trends and Insights By Type...
-
Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth services and blockchain-based innovation, today announced that its...
-
Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative à capital variable, agréée en tant qu’établissement de crédit Siège social : 500 rue Saint-Fuscien 80095 AMIENS...
-
Press ReleaseProRail selects Nokia to modernize the Netherlands’ railway GSM-Railway core network Upgrades will reduce downtime, cut long-term costs, and improve service reliability.The four-year...
-
Austin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Carbon Fiber Tapes Market Size was valued at USD 3.06 billion in 2024 and is expected to reach USD 9.66 billion by 2032, growing at a CAGR of 15.47%...
-
Austin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Household Vacuum Cleaners Market Size & Growth Insights: According to the SNS Insider Report, “The Household Vacuum Cleaners Market size was valued at...
-
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency...
-
Communiqué de presseNicox annonce l’initiation par son partenaire Kowa d’un essai clinique de Phase 3 pour NCX 470 au Japon Kowa, le partenaire exclusif de Nicox au Japon, a initié un essai clinique...
-
Press Release Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan Exclusive Japanese partner Kowa has initiated a Phase 3 safety clinical trial of NCX 470 for the treatment of...